Ignorer et passer au contenu
Accueil / Polices / Elsner+Flake / EF DIN 1451
EF DIN 1451

EF DIN 1451

par Elsner+Flake
Styles individuels à partir de $35.00 USD
EF DIN 1451 Font la famille était conçu par publié par Elsner+Flake. EF DIN 1451 contient 4 styles.

En savoir plus sur cette famille
ESSAI GRATUIT DE 30 JOURS de Monotype Fonts pour obtenir plus de 150 000 polices de plus de 1 400 fonderies de caractères. Démarrer l'essai gratuit
Démarrer l'essai gratuit

    Réinitialiser

    À propos de la famille EF DIN 1451 Police


    Concepteurs:

    Éditeur: Elsner+Flake

    Fonderie: Elsner+Flake

    Maître d'ouvrage: Veronika Elsner, Günther Flake

    MyFonts débout: Jul 25, 2001

    EF DIN 1451

    À propos Elsner+Flake

    About Elsner+Flake

    In March 1986 Veronika Elsner and Günther Flake founded their company Elsner+Flake Designstudios after ten years of freelance experience in the field of type design, typography and digitizing of fonts and logos. The general aim of the company is to create a continuously growing library of digital fonts. Today the Elsner+Flake Digital Library with a worldwide presentation and appreciation contains more than 2,500 fonts, which are available in Mac PostScript, PC PostScript and PC Truetype.

    Typography with a Difference

    Electronic modification is avoided, all italics are digitized from original artwork. Text and headline typefaces have matching cap heights and contain standard character layouts. Complete kerning tables guarantee a precise appearance and excellent legibility. Accents on caps and lowercase letters are individually designed. Many typefaces feature small caps and old style numbers. Most fonts are already completed with the new euro currency symbol.

    Partners Worldwide

    Elsner+Flake cooperates worldwide with more than thirty-five business partners. In case of questions concerning the Elsner+Flake Digital Library or to order a specimen catalogue please contact the address given. We will introduce you to your closest Elsner+Flake distributor.

    En savoir plus